TrialHIV clinical trials2017

Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128).

Rima Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.